KUMIAI CHEMICAL IND sees an upgrade to Slightly Positive due to a better fundamental star rating
The general evaluation of KUMIAI CHEMICAL IND (JP), a company active in the Speciality Chemicals industry, has been upgraded by the independent financial analyst theScreener with the addition of a star. Its fundamental valuation now shows 4 out of 4 possible stars while its market behaviour can be considered as moderately risky. theScreener believes that the additional star(s) merits the upgrade of its general evaluation to Slightly Positive. As of the analysis date February 4, 2022, the closing price was JPY 817.00 and its potential was estimated at JPY 917.36.Kumiai Chemical Industry is mainly engaged in the manufacture and sale of chemical products. Along with its subsidiaries and associated companies, Co. operates in three business segments. Agricultural Chemicals segment: It is engaged in the synthesis, manufacture and sale of agricultural chemicals, such as insecticides, bactericides and herbicides, as well as the sale of non-agricultural land-use medical agents. Fine Chemicals segment: It is engaged in the manufacture and sale of chlorotoluene intermediate products, fine chemicals, industrial chemicals, and styrene foam. Others segment: It is engaged in the leasing of real estate.
Empowering Investors
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
- Worldwide coverage: theScreener analyses cover around 6'500 Stocks, i.e 95% of the world Market Capitalization. theScreener state of art: We provide
- theScreener state of art: We provide easy to use and complete analyses over Stocks, including Fundamentals / Technical / Risk/ Peer / Alternatives analyses.
- For Research Pool community, we provide twice a week around 500 new equity analyses. We produce analyses about equities which have been upgraded or downgraded.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.